PharmEasy Valuation Slashed 92% From Peak In Latest Janus Henderson Filing
The valuation of API Holdings Pvt., the owner of PharmEasy, was slashed by about 92% to $460 million by US-based investor Janus Henderson as the once-IPO-bound startup sees a severe markdown in value.
At the end of 2021, Janus Henderson valued the company at roughly $5.6 billion, given its holding of 7.58 lakh shares in PharmEasy. In its latest filings with the US Securities and Exchange Commission, the value of the same shares has dipped by 92%, pegging PharmEasy's worth at around $460 million.
The struggling e-pharmacy had already seen a 90% slash from its peak valuation in April this year, when it raised Rs 1,800 crore, led by billionaire Ranjan Pai's Manipal Education and Medical Group and existing investors.
The e-pharmacy's expanding losses and minimal revenue growth in financial year 2023 are the reasons for the valuation cut. It posted Rs 6,644 crore in consolidated revenue from operations, up roughly 16% from Rs 5,728.8 crore in the previous fiscal.
The company's loss widened to Rs 5,211.7 crore from Rs 3,992.4 crore in FY22, according to financial statements on the company's website. It is also bogged down by the growing prominence of rival e-pharmacies such as Tata 1mg, Medlife, Flipkart's SastaSundar.com (now Flipkart Health+) and Reliance-backed Netmeds.
Another US investor, Neuberger Berman, cut PharmEasy's valuation by 21% to $4.4 billion as of February 2023. Global investor Prosus has also marked Pharmeasy's performance as one of the poorest in its portfolio, a shade of fellow Indian companies Swiggy and PayU.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
